News and Announcements
Actinogen Medical Provides Quarterly Newsletter Focusing on Brain Awareness Week
- Published March 16, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Actinogen Medical is pleased to provide its latest quarterly newsletter which focuses on Brain Awareness Week (13-19 Mar 2017) – a global campaign to increase public awareness of the progress and benefits of brain research.
KEY TAKEAWAYS:
- One-in-three people will develop Alzheimer’s disease by the time they are 85 and available health budgets cannot cope with managing this disease – it already costs US$250 billion annually in the US alone.
- Dr Bill Ketelbey reflects on his own personal journey to seek a cure for Alzheimer’s disease and the reasons why he joined Actinogen.
- Recent key Australian research may have provided an important clue to how best to develop a new treatment for Alzheimer’s disease and this is why Actinogen Medical’s XanADu program is so keenly watched.
Please Click below for the full Quarterly Investor Newsletter.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
